HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical features and outcomes of 49 Turkish patients with acute promyelocytic leukemia who received ATRA and anthracyclines (PETHEMA protocol) therapy.

AuthorsSongul Serefhanoglu, Yahya Buyukasik, Hakan Goker, Nilgun Sayinalp, Ibrahim Celalettin Haznedaroglu, Salih Aksu, Osman Ilhami Ozcebe, Mehmet Turgut, Rahmi Aslan, Evren Ozdemir
JournalLeukemia research (Leuk Res) Vol. 34 Issue 12 Pg. e317-9 (Dec 2010) ISSN: 1873-5835 [Electronic] England
PMID20696473 (Publication Type: Letter)
Chemical References
  • Anthracyclines
  • Tretinoin
  • Idarubicin
Topics
  • Adolescent
  • Adult
  • Aged
  • Anthracyclines (administration & dosage, adverse effects)
  • Antineoplastic Combined Chemotherapy Protocols (administration & dosage, adverse effects)
  • Disease-Free Survival
  • Female
  • Humans
  • Idarubicin (administration & dosage, adverse effects)
  • Leukemia, Promyelocytic, Acute (drug therapy, mortality)
  • Male
  • Middle Aged
  • Retrospective Studies
  • Survival Rate
  • Tretinoin (administration & dosage, adverse effects)
  • Turkey

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: